The article below may contain offensive and/or incorrect content.
MP-Pt(IV), a second generation prodrug appears to have curative properties against glioblastoma when coupled with chemotherapy in mouse models.Article Correctness Is Author's Responsibility: Experimental Glioblastoma Therapy Shows Curative Powers
MP-Pt(IV), a second generation prodrug appears to have curative properties against glioblastoma when coupled with chemotherapy in mouse models.
